Chemours Co insider trading
Every open-market purchase and sale by Chemours Co's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Chemours Co’s insiders pay?
From September 8, 2015 to August 13, 2026, 28 insiders reported 39 open-market purchases and 33 sales not made under a pre-set plan in Chemours Co. Twelve months after each purchase was reported, the shares were +73.0% against the S&P 500 on average (median +35.5%), over 32 purchases with a full year of prices; 78% beat the index. After sales, the shares moved −21.6% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on September 9, 2015 into $92,561 by November 2, 2026, +22.1% a year. It held shares 68% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $42,767 (+14.0% a year), and held throughout $46,696 (+14.9%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Newman Mark | President and CEO | 5 | +88.6% (5) | 80% | 4 | −27.6% (4) | June 12, 2023 |
| Snell E Bryan | President, Titanium Tech | 4 | +111.8% (4) | 100% | 3 | −9.8% (3) | November 12, 2020 |
| Scarborough Alvenia | SVP Corp Communications & CBO | 0 | — | — | 4 | −27.8% (4) | November 12, 2024 |
| Shelton David C | SVP, GC & Corp. Secretary | 2 | +34.4% (2) | 100% | 2 | −27.3% (2) | May 9, 2022 |
| Sparks Edwin C | President, Titan Tech Chem Sol | 0 | — | — | 4 | −1.4% (4) | June 9, 2022 |
| Trojanowski Amy | VP and Controller | 1 | +37.1% (1) | 100% | 3 | −51.5% (3) | March 15, 2019 |
| Bell Bradley J | Director | 3 | +101.9% (3) | 67% | 0 | — | August 6, 2019 |
| Bellezza Alisha | President, Thermal Spec Solns | 0 | — | — | 3 | −20.5% (3) | March 7, 2023 |
| Brown Richard H | Director | 3 | +7.8% (3) | 67% | 0 | — | March 4, 2020 |
| Cranston Mary B | Director | 3 | +0.2% (2) | 50% | 0 | — | August 11, 2026 |
| Dignam Denise | Chief Executive Officer | 2 | −10.5% (1) | 0% | 1 | +12.9% (1) | August 13, 2026 |
| Kirsch Paul | President - Fluoroproducts | 0 | — | — | 3 | −25.9% (3) | February 27, 2019 |
| Siemer Christian W | President, Chemical Solutions | 2 | +36.6% (2) | 100% | 1 | −40.2% (1) | December 15, 2017 |
| Abbott Matthew S | SVP, Chief Enterprise Transfor | 0 | — | — | 2 | −10.4% (2) | June 9, 2023 |
| Hostetter Shane | Chief Financial Officer | 2 | +78.0% (1) | 100% | 0 | — | August 10, 2026 |
| Newlin Stephen D | Director | 2 | +280.5% (2) | 100% | 0 | — | February 29, 2016 |
| Vergnano Mark | President and CEO | 2 | −3.5% (2) | 50% | 0 | — | June 10, 2019 |
| Anastasio Curt | Director | 1 | +35.5% (1) | 100% | 0 | — | August 6, 2019 |
| Cowan Alister | Director | 1 | — | — | 0 | — | August 11, 2026 |
| Familiar Calderon Gerardo | See Remarks | 1 | — | — | 0 | — | August 13, 2026 |
| Foley Michael Robert | See Remarks | 1 | — | — | 0 | — | August 11, 2026 |
| Gumpel Damian | See Remarks | 1 | +73.9% (1) | 100% | 0 | — | June 4, 2025 |
| Kelliher Susan M. | SVP, People & Health Services | 1 | −47.7% (1) | 0% | 0 | — | May 20, 2019 |
| Martinko Joseph T. | See Remarks | 1 | — | — | 0 | — | August 11, 2026 |
| Parker Erich | VP Corp Comm & CBO | 0 | — | — | 1 | +3.9% (1) | May 18, 2017 |
| Picho Diane I. | Interim Pres. - Titanium Tech | 0 | — | — | 1 | −37.4% (1) | August 8, 2024 |
| Ralhan Sameer | SVP, CFO | 0 | — | — | 1 | −27.9% (1) | May 9, 2022 |
| Vanlancker Thierry Fj | President - Fluoroproducts | 1 | +255.7% (1) | 100% | 0 | — | November 25, 2015 |
When several insiders traded Chemours Co
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Chemours Co in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 5 buying crowds with six months of prices, it averaged +45.5% against the index. After 4 selling crowds, −20.9%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| August 31, 2026 | 7 buying | not yet | not yet | not yet |
| June 30, 2025 | 2 buying | +29.3% | −6.1% | +57.7% |
| May 31, 2022 | 6 selling | −16.5% | −23.5% | −39.0% |
| June 30, 2021 | 3 selling | −17.0% | −15.4% | +5.5% |
| March 31, 2020 | 2 buying | +56.7% | +106.7% | +176.3% |
| May 31, 2019 | 3 buying | −39.7% | −36.5% | −44.1% |
| March 29, 2019 | 3 selling | −39.0% | −65.3% | −66.8% |
| June 30, 2017 | 3 selling | +29.1% | +20.7% | +2.2% |
| May 31, 2016 | 2 buying | +48.2% | +156.1% | +344.3% |
| September 30, 2015 | 7 buying | −26.6% | +7.1% | +123.5% |